Scientists for the Food and Drug Administration say that an Amgen drug slowed the spread of cancer to the bone in men with hard-to-treat prostate cancer, though the drug did not extend life and carried significant side effects.

GLOSTRUP, DENMARK-- -The wait is over for cancer patients: Dako, a global leader in tissue-basedcancer diagnostics, now introduces IQISH technology which will allowdiagnosisof cancer to go from days to ...

Yuvraj Singh's cancer is curable and the hard-hitting Indian batsman is likely to be back in training in May, a New Delhi oncologist said on Monday.

NEW YORK, Feb. 6, 2012  /PRNewswire/ --  Reportlinker.com announces that a new market research report is available in its catalogue: Triple Analysis: Breast Cancer, Pancreatic Cancer and Angiogenesis http://www.reportlinker.com/p0284795/Triple-Analysis-Breast-Cancer-Pancreatic-Cancer-and-Angiogenesis.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=PathologyThis ...

NEW YORK, Feb. 6, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Triple Analysis: Breast Cancer, Prostate Cancer and Angiogenesis http://www.reportlinker.com/p0284682/Triple-Analysis-Breast-Cancer-Prostate-Cancer-and-Angiogenesis.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=PathologyThis ...

The cancer of India cricketer Yuvraj Singh is curable, one of his doctors says, and he could be back on the field by May.

THE IRISH Cancer Society is to create a number of “virtual� research centres that will bring together large groups of scientists all targeting a specific type of cancer. It also plans a national cancer research centre aimed at developing cancer treatments, the society’s new director of research has said.

Cancer was responsible for almost half of all deaths in Ireland last year, a study suggests.

The president of Memorial Sloan-Kettering Cancer Center is in a billion-dollar dispute with his former workplace over accusations that he walked away with research.

The president of Memorial Sloan-Kettering Cancer Center, Dr. Craig B. Thompson, is in a billion-dollar dispute with his former workplace over accusations that he walked away with research.